MannKind: Afrezza Delayed Again: "
Click to view a price quote on MNKD.
Click to research the Drugs industry."
VALENCIA, Calif. (TheStreet) --MannKind copped to even more delays with the development of its inhaled insulin delivery device.
On its quarterly conference call Monday, MannKind said the design of two clinical studies of the Afrezza diabetes device were still being finalized, and as such, neither study would likely be completed until the end of 2012, based on current estimates.
MannKind's timeline estimates stopped there, but some simple math and common sense says the U.S. Food and Drug Administration isn't likely to be in a position to issue a third approval decision until the second half of 2013. Even that estimate might be too optimistic.
...
Click to view a price quote on MNKD.
Click to research the Drugs industry."
Comments